To get somewhere close you need to:that will get you a valuation for FSGS.
- work out the NPV of the recent licensing deal for europe, AU & NZ markets ($230m + 15-20% royalty on $1B per annum market with no other competitors)
- apply same value to US & China pro rata
Then there's DKD which has 10x the market size of FSGS and was headed into the next trial phase (possibly phase 3) which is to be run and funded by ACADI. Haven't heard much on this lately though...
There's also COPD but that's very early stages.
To get somewhere close you need to:work out the NPV of the...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.015(4.69%) |
Mkt cap ! $184.1M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 34.0¢ | 31.0¢ | $1.526M | 4.675M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 24995 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 416229 | 11 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
33.5¢ |
Change
0.015 ( 4.62 %) |
||||
| Open | High | Low | Volume | ||
| 32.0¢ | 34.0¢ | 31.0¢ | 2395296 | ||
| Last updated 15.58pm 02/05/2024 ? | |||||
| DXB (ASX) Chart |